Other studies have reported that the empagliflozin/metformin combination reduced ALT levels, body weight, and glycosylated hemoglobin, and significantly improved fibrosis and ultrasound steatosis grades compared to metformin alone [35,36,37]. The gene discussed is GPT; the disease is steatosis.